Source:http://linkedlifedata.com/resource/pubmed/id/18050308
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2008-4-8
|
pubmed:abstractText |
The hypothesis tested in this study was that perioperative administration of the bisphosphonate zoledronate will reduce strain protection-related calcar osteopenia and maintain functional integration of the femoral component in an ovine hemiarthroplasty model. Twelve sheep received a unilateral cemented hemiarthroplasty where six animals were given nine intravenous infusions of zoledronate (10 microg/kg) pre-, peri-, and postsurgery over 8 months. Control animals received physiological saline only. Implants remained in vivo for 9 months. Ground reaction force (GRF) was used to assess functional loading of the implanted limb, bone mineral density (BMD) was quantified using dual energy X-ray absorptiometry (DEXA). Cortical bone area, thickness, and viable osteocytes were assessed histologically. No significant differences in GRF data between groups was identified. Results demonstrated a significant drop in BMD values in the control group (9.7%) when compared with the bisphosphonate-treated group (3.2%) (p = 0.0159). Histological results showed that cortical area, thickness, and the percentage of lacunae with viable osteocytes was significantly greater in the bisphosphonate-treated group when compared with control (p = 0.002, p = 0.001, p = 0.003, respectively). The administration of zoledronate reduced cortical osteopenia in the calcar region of the proximal femur and this therapy could be used as a preventive measure to combat strain protection osteopenia and its contribution to associated aseptic loosening in total hip replacement surgery.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1554-527X
|
pubmed:author | |
pubmed:copyrightInfo |
(c) 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
693-703
|
pubmed:meshHeading |
pubmed-meshheading:18050308-Animals,
pubmed-meshheading:18050308-Arthroplasty, Replacement, Hip,
pubmed-meshheading:18050308-Bone Density,
pubmed-meshheading:18050308-Bone Density Conservation Agents,
pubmed-meshheading:18050308-Bone Diseases, Metabolic,
pubmed-meshheading:18050308-Diphosphonates,
pubmed-meshheading:18050308-Female,
pubmed-meshheading:18050308-Hip Joint,
pubmed-meshheading:18050308-Imidazoles,
pubmed-meshheading:18050308-Locomotion,
pubmed-meshheading:18050308-Microradiography,
pubmed-meshheading:18050308-Prosthesis Failure,
pubmed-meshheading:18050308-Random Allocation,
pubmed-meshheading:18050308-Sheep,
pubmed-meshheading:18050308-Stress, Mechanical
|
pubmed:year |
2008
|
pubmed:articleTitle |
Prevention of strain-related osteopenia in aseptic loosening of hip prostheses using perioperative bisphosphonate.
|
pubmed:affiliation |
The Institute of Orthopaedics and Musculoskeletal Science, University College London, The Royal National Orthopaedic Hospital Trust, Brockley Hill, Stanmore, Middlesex HA7 4LP, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|